Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery

B BOSTON and HANGZHOU, China, May 11, 2026 /PRNewswire/ — Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary clinical results…
posteditor
posteditor
Articles: 21727

Other News